Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yt90-Zevalin Consolidation in DLBCL
NCT00440583Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Sep 2006
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in diffuse large B-cell lymphoma (DLBCL), sponsored by Mahidol University. Started Sep 2006; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00440583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440583.